Does History Favor Buying This Dip in Universal Technical Institute Stock?

UTI: Universal Technical Institute logo
UTI
Universal Technical Institute

The technician training school is growing fast, but so are its costs, and the stock’s track record after a fall offers a clue for what might come next.

Universal Technical Institute (UTI) is executing a clear strategy: open more campuses, launch more programs, and train more technicians for an economy hungry for skilled labor. On its latest call, management pointed to strong demand and validation of its “North Star” growth plan, with total new student starts up 14% year-over-year. New campuses are hitting the ground running; the one in San Antonio, for instance, saw its first two student cohorts exceed plans by nearly 60%.

Yet, the stock has pulled back about 13% in recent weeks. The market seems less focused on the growth and more on the cost of achieving it. An analyst on the company’s last earnings call pointedly asked why operating expenses were up 16% when revenue grew about 7%. That’s the question at the heart of this dip: is this a temporary wobble in a great growth story, or a warning sign about profitability? Let’s look at the evidence.

Trefis: UTI Stock Insights

What The Past Says About Buying The Dip

Relevant Articles
  1. Is Zillow Stock’s Recent Slide a Trap or an Opportunity?
  2. Kadant Stock Is Flashing A Green Light, But Is It A Trap?
  3. What History Says About Buying a Dip in Zillow Stock
  4. MongoDB Stock Is Cheaper, But Is It a Bargain?
  5. Rocket Lab Stock’s Strong Flight Hides A Steep Fall
  6. The Downside You Own in Salesforce Stock

When a stock like UTI takes a sharp fall, the first question is whether it tends to bounce back. History offers a moderately encouraging, if not definitive, guide. Since 2010, the stock has suffered a steep drop of 20% or more within a single month on 16 separate occasions. Following those drops, the stock delivered a positive return over the next year 9 times.

The median return in the twelve months after a dip was 8%. However, buying the dip has rarely been a painless trade. Investors who bought in typically had to endure a median worst further drawdown of 27% before the stock recovered. The detailed record below shows the full range of outcomes, which have varied widely.

UTI had 16 events since 1/1/2010 where the dip threshold of -20% within 30 days was triggered

  • 28% median peak return within 1 year of dip event
  • 204 days is the median time to peak return after a dip event
  • -27% median max drawdown within 1 year of dip event

Period Past Median Return
1M -2.9%
3M 6.9%
6M 4.4%
12M 8.2%
30 Day Dip UTI Subsequent Performance
Date UTI SPY 1Y Peak
Return
Max
Drop
# Days
to Peak
Median     8% 28% -27% 204
11202025 -23% -3% 67% 91% -7% 196
8112025 -25% 3% 52% 74% -15% 297
9152022 -22% -6% 29% 32% -18% 361
6132022 -26% -9% -14% 9% -30% 51
9212020 -20% -2% 8% 13% -29% 352
3112020 -24% -16% 8% 44% -37% 148
8172018 -20% 4% 69% 77% -6% 357
12122017 -20% 4% 25% 31% -11% 213
9162016 -22% -1% 59% 85% -27% 236
5022016 -23% 2% -2% 2% -59% 322
12022015 -24% 3% -34% 24% -62% 110
7242015 -29% -1% -56% 7% -64% 7
12152014 -21% -1% -55% 13% -62% 114
11282012 -35% -1% 71% 71% 0% 364
8122011 -21% -10% -25% 0% -26% 0
8052010 -21% 3% -8% 25% -17% 147
[1] Dip event defined as first instance dip threshold is triggered within a 30-day time period.
[2] Analysis for period from 1/1/2010 to 6/9/2026

But This Only Works If The Business Is Sound

Of course, buying a dip only makes sense if the underlying business is sound. A falling stock price for a deteriorating company is a trap, not an opportunity. On that front, UTI appears to be on solid footing. The business clears every basic quality check on a simple scorecard of growth, cash generation, and balance-sheet strength.

Over the trailing twelve months, the company grew revenue 11.0%, and its operating cash flow margin was a healthy 9.5%. This suggests the recent stock weakness isn’t a reflection of a broken business model, but rather a debate about its future profitability and current price.

Quality Metrics Value Quality Check
Revenue Growth (LTM) 11.0% Pass
Revenue Growth (3-Yr Avg) 21.2% Pass
Operating Cash Flow Margin (LTM) 9.5% Pass
Leverage (see below) Pass
=> Interest Coverage Ratio 14.2  
=> Cash To Interest Expense Ratio 38.0  

Is This Dip Different From The Last Ones?

So, is this dip an opportunity? The case for it rests on the idea that the market is overreacting to short-term investment spending. Management believes the demand for its graduates is a “structural” trend, not a cyclical one, fueled by everything from the build-out of AI data centers to chronic labor shortages. If they are right, the current spending on new campuses and programs is simply the necessary cost to capture a large, multi-year opportunity.

The hesitation comes from two places. First, the costs are real and immediate. Management confirmed that investors should expect “year-over-year contraction” in adjusted EBITDA in the third quarter before a hopeful rebound. Second, even after the recent drop, the valuation looks very high. UTI trades at a price-to-earnings ratio of about 51, compared to roughly 24 for its peer benchmark. Buyers of this dip are still paying a significant premium for growth that, while strong, is currently coming with shrinking near-term profits.

Ultimately, your decision rests on whether you believe the company can grow into that premium valuation. The one thing to watch in the next earnings report is the gap between revenue growth and operating expense growth. If that gap begins to narrow, it would be strong evidence that the company’s investments are starting to pay off and generate the profitable scale bulls are counting on.

Wondering which other quality stocks have just sold off, and whether their past dips have tended to recover? You can screen the market’s recent pullbacks on our Buy The Dip rankings.

Beyond Timing A Single Dip

Buying the dip on one stock looks easy on a chart, but living through it is hard. A “bargain” that keeps falling, tests your nerve, and the temptation to sell at the bottom is exactly what derails most dip buyers. Catching the rebound takes a plan that makes staying invested a discipline rather than a test of willpower. That is the idea behind the Trefis High Quality (HQ) Portfolio, which holds 30 quality stocks, sized and rebalanced with discipline, and has a track record of outpacing the S&P 500, S&P Mid-cap, and Russell 2000. Pairing a single-name dip with a diversified core is how you keep the upside while smoothing the swings that shake investors out at the worst moment.